HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsutoshi Kato Selected Research

Mitsutoshi Kato Research Topics

Disease

9Type 2 Diabetes Mellitus (MODY)
01/2021 - 10/2004
4Body Weight (Weight, Body)
01/2021 - 02/2009
3Hypertension (High Blood Pressure)
01/2021 - 01/2014
2Obesity
09/2021 - 02/2019
1Hypotension (Low Blood Pressure)
01/2021
1Insulin Resistance
01/2021
1COVID-19
01/2020
1Weight Loss (Weight Reduction)
02/2019
1Heart Failure
11/2018
1Diabetes Mellitus
11/2018
1Cardiovascular Diseases (Cardiovascular Disease)
11/2018
1Essential Hypertension
01/2014

Drug/Important Bio-Agent (IBA)

4Sodium-Glucose Transporter 2 InhibitorsIBA
01/2021 - 11/2018
3dapagliflozinIBA
01/2021 - 02/2019
3SodiumIBA
01/2021 - 01/2014
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 11/2018
3SaltsIBA
11/2018 - 10/2004
2Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2019
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2021 - 11/2018
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2021 - 11/2018
2Angiotensin Receptor AntagonistsIBA
01/2021 - 11/2018
2empagliflozinIBA
01/2021 - 11/2018
1ORALIT (ORS)IBA
09/2021
1Uric Acid (Urate)IBA
01/2021
1CarbohydratesIBA
02/2019
1VitaminsIBA
02/2019
1Antihypertensive Agents (Antihypertensives)IBA
11/2018
1LipidsIBA
08/2017
1ipragliflozinIBA
08/2017
1VildagliptinIBA
02/2009
1MagnesiumIBA
10/2004

Therapy/Procedure

4Therapeutics
09/2021 - 08/2017
3Glycemic Control
01/2020 - 02/2009